Advanced Filters
noise

Seoul, etc., Korea, Republic of Clinical Trials

A listing of Seoul, etc., Korea, Republic of clinical trials actively recruiting patients volunteers.

Found 64,783 clinical trials
H Hanane Fodil

Beta-Lactams Dosing In Pneumonia in ICU in Patients Treated by Continuous Renal Replacement Therapy: the BLIPIC Study

Pneumonia are the most frequent infections in ICU. Little is known about beta-lactam doses necessary for this infection for patients treated with continuous veino-veinous hemodialysis. The pharmacokinetic variability expose to over and underdosage leading to toxicity or therapeutic failure. The aim of this study is to define if beta-lactams doses …

18 years of age All Phase N/A
H Hsiao-Yun Hsieh, MSc

Pyroptosis and Ferroptosis in the Pathophysiology of Lymphedema

The project aims to compare the differences in the expression of cell death through apoptosis and iron-dependent cell death after the reduction of edema symptoms following lymphedema surgery in patients.

20 - 100 years of age All Phase N/A
E Emilio Bria, Professor

Longitudinal Assessment of Genomic Alterations and Clonal Evolution in ALK-positive NSCLC (Galileo Project)

The scope of GALILEO project (Genomic ALteratIons and cLonal EvOlution in ALK+ NSCLC) is to explore the feasibility of genomic longitudinal evaluation for ALK+ NSCLC patients in Italian routine practice and provide a detailed overview of resistance mechanisms and clinical outcomes according to current standard treatments.

18 years of age All Phase N/A

Impact of COVID-19 on Quality of Life of Seniors With Eye Disease and Implementations to Improve Wellness

The ophthalmology clientele is vulnerable in the context of the coronavirus disease 2019 (COVID-19) pandemic because of their age and comorbidities. Specifically, elderly patients aged 65 and above with glaucoma, age-related macular degeneration, or diabetic retinopathy require regular follow-ups and commonly suffer from additional comorbidities. Further, because of the proximity …

65 years of age All Phase N/A
D Damien LELEU

Lipid Characterisation of Plasma Microparticles in a Large Population of Healthy Donors

Extracellular vesicles (EVs) are membrane structures containing numerous mediators categorised according to their size and mode of production. Among them, microparticles (MPs) are EVs between 100 nm and 1 μm in size that are produced by budding at the plasma membrane of different cell types following different mechanisms of cell …

18 years of age All Phase N/A
C Chunyan Sun, MD

The Prognostic Value of CPCs Quantified by Flow Cytometry in Patients With Multiple Myeloma: a Prospective, Multicenter Clinical Trial

This study aims to investigate the prognostic value of circulating plasma cells (CPCs) in patients with multiple myeloma and explore whether CPCs detection might be used in place of bone marrow aspiration for disease monitoring.

18 - 80 years of age All Phase N/A
A Aslı ÇELİK, MSc.

Unidimensional Self-Efficacy Scale for Multiple Sclerosis (USE-MS) Turkish Adaptation

Multiple Sclerosis (MS) is a chronic, inflammatory, demyelinating, autoimmune disease of the central nervous system. Despite functional limitations and unpredictable disease course, individuals with MS are aimed to maintain different levels of independence according to the level of disability. It is aimed to develop interventions that aim to increase self-efficacy …

18 years of age All Phase N/A

Breech External Cephalic Version Intervention Trial

A prospective study assessing the use of external cephalic version for the management of breech presentation in pregnancy.

18 years of age Female Phase N/A
Z Zachary Sone

Role of Insulin Action in Psoriasis Pathogenesis

The goal of this study is to collect more information from people with plaque psoriasis and to determine if insulin plays a role in the pathogenesis of psoriasis. The main question it aims to answer is if insulin action is preserved or even enhanced in psoriatic lesions despite insulin resistance …

18 - 65 years of age All Phase N/A
L Laura BUSCEMI

Natural History Study for Patients With Angelman Syndrome

This study is a 4-year natural history study for patients with Angelman syndrome in Belgium (a genetic neurodevelopmental disorder, affecting 500,000 individuals in the world). It includes a 1-year recruitment phase, a 2-year follow-up and a year to analyze the collected data. The investigators plan to include 10 patients with …

years of age All Phase N/A

Simplify language using AI